20273 results for «»
20273 results
#2 - How can I minimise paravalvular leak for my TAVI patients?
29 Jun 2021
Watch this PCR Webinar with A. Latib, M. Reardon and L. Sondergaard
Patent foramen ovale (PFO) closure with stroke
18 May 2021 – From EuroPCR 2021
Watch this session presented by Engin Bozkurt in order to know more about incidence about stroke caused to younger people, to follow the guideline trend towards patent foramen ovale (PFO) closure, and to learn the future of PFO and device trends.
HIGHLIFE transseptal mitral valve replacement (TSMVR): step by step
18 May 2021 – From EuroPCR 2021
Watch this session presented by Wolfgang Rottbauer in order to learn about the HighLife transseptal mitral valve replacement procedure, to understand the interaction between the devices and the anatomy and to be familiar with upcoming technologies in structural heart procedures.
Early real-world experience with Tendyne™ TMVR
18 May 2021 – From EuroPCR 2021
Watch this session presented by Stephan von Bardeleben in order to learn about real-world Tendyne results from TENDER EU, the largest reported commercial cohort, to hear expert feedback on the safety and effectiveness of Tendyne TMVI in real-life setting, and to discover how one heart team integrates Tendyne...
Cool AMI EU pivotal trial- final results after trial discontinuation following ad interim analysis
18 May 2021
Results of the interim analyses performed after 12 months in the first 111 patients enrolled in phase II Cool AMI trial evaluating safety and effectiveness of systemic therapeutic hypothermia as an adjunctive therapy in anterior STEMI undergoing PCI as compared to PCI only. Analyses showed significant...
TAVI in bicuspid aortic valve patients. SAPIEN 3 platform, a safe and efficient option
19 May 2021 – From EuroPCR 2021
Watch this session presented by Philippe Genereux, Didier Tchetche, Joerg Kempfer, Radoslaw Parma and Christoph Klein in order to understand which patients with bicuspid aortic valve are suitable for TAVI vs. SAVR, to learn about Edwards SAPIEN 3 being utilisation in patients with bicuspid aortic valve, and to know more about the...
A review of the RADIANCE-HTN global clinical trial programme: a focus on the TRIO cohort
18 May 2021 – From EuroPCR 2021
Watch this session presented by Ajay Kirtane, Melvin David Lobo and Felix Mahfoud in order to review a history of the field and the recent clinical advancements in renal denervation with the Paradise Ultrasound RDN system, to further examine the recently announced results from RADIANCE-HTN TRIO (blinded, sham-controlled, powered...
EBC MAIN trial results – what is new and what will change in left main stenting?
18 May 2021
The European Bifurcation Club Left Main (EBC MAIN) trial addressed the issue of provisional single stent versus upfront double stenting in 467 patients with true bifurcation distal left main disease.
So far, only one other randomized trial, DKCRUSH-V (n=482), has addressed the same research question, showing better...
Introducing Navitor: a new TAVI solution
18 May 2021 – From EuroPCR 2021
Watch this session presented by Helge Möllmann, Lars Sondergaard, Maurizio Taramasso, Ganesh Manoharan and Dave Smith in order to discuss how to minimise resources needed for your TAVI procedure without compromising safety and efficacy, to demonstrate how to simplify your TAVI procedure, and to examine considerations for lifetime management of your...
A randomised trial comparing imaging-guided PCI with Orsiro vs Xience
18 May 2021
Previous clinical trials suggested that ultra-thin strut biodegradable polymer sirolimus-eluting stent (BP-SES) may be associated with lower target lesion failure (TLF) when compared to durable polymer everolimus-eluting stents (DP-EES). However, the possible underlying mechanisms remain unclear. Therefore, the all-comers CASTLE study was designed to assess the...
Authors :
PCR STATEMENT on the 2-year clinical outcomes from the Evolut low risk trial
18 May 2021
Transcatheter aortic valve implantation (TAVI) offers an effective, less invasive therapeutic alternative to surgical aortic valve replacement in patients with symptomatic, severe aortic stenosis. Although TAVI is demonstrated to be superior to medical therapy or surgery in patients who are at prohibitive or high risk for...
One-year results from the FUTURE-II trial
18 May 2021
A decade already passed from the first use of bioresorbable vascular scaffold in percutaneous coronary interventions. The first studies - by using surrogate endpoints - showed some superiority of BRS vs. metallic drug-eluting stent in terms of the so-called vascular restoration therapy with recovery of vasomotion...
EAPCI-PCR Fellows Course: interventions for calcified coronary lesions
18 May 2021 – From EuroPCR 2021
Watch this session if you want to review the role of imaging for procedural planning and to discuss the best indications for specific plaque modification techniques.
This session was originally presented during EuroPCR 2021.
A new meta-analysis supports elective revascularization and medical therapy for reducing cardiac death
18 May 2021
The ISCHEMIA trial found no significant difference between an invasive vs. a conservative strategy in patients with chronic coronary syndromes and moderate to severe ischemia at a mean of 3.2 years. However, the cumulative difference in the estimates of cardiac death between the invasive and conservative...
EuroPCR 2021 Hotlines / Late-Breaking Trials: TRILUMINATE, CLASP TR, bRIGHT, TRISCEND, TriBAND, and more!
21 May 2021 – From EuroPCR 2021
Find out more about various studies & registries in TRICUSPID:
- Percutaneous E2E repair for TR: 2-Year outcomes from the TRILUMINATE trial
- Transcatheter tricuspid valve repair: CLASP TR feasibility study 6-month results
- Clinical Response to Transcatheter treatment of tricuspid regurgitation: International TriValve registry
- Baseline characteristics and procedure outcomes from TriClip bRIGHT...
EuroPCR 2021: Opening Ceremony - Education & Innovation in Interventional Cardiovascular Medicine
18 May 2021 – From EuroPCR 2021
Did you miss the livestream of EuroPCR 2021’s official Opening Ceremony? Look back to watch the PCR Chairman William Wijns and PCR Vice-Chairman Jean Fajadet launch this innovative edition of the Course. More than ever it was the right place to be!
Couldn’t join the 2021 Andreas Grüntzig Ethica Award Ceremony? Want to view photos?
EuroPCR 2021 - Innovations in peripheral and structural interventions
18 May 2021 – From EuroPCR 2021
In this session, discover how an effective calcium debridement procedure in stenotic aortic valves may restore the valve function, and why biometric indicators and engineering characteristics are so important for effective and safe delivery of endovascular care.
DANIEL GITELSON
MOSCOW, Russian Federation
Andrej Pileckij
Klaipeda, Lithuania